{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 35059, "items": [{"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T17:20:11Z", "timestamp": 1576776011683}, "edition-number": "1", "reference-count": 0, "publisher": "Cambridge University Press", "isbn-type": [{"value": "9780521622639", "type": "print"}, {"value": "9780511527098", "type": "electronic"}], "license": [{"URL": "https://www.cambridge.org/core/terms", "start": {"date-parts": [[2010, 1, 6]], "date-time": "2010-01-06T00:00:00Z", "timestamp": 1262736000000}, "delay-in-days": 3429, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2000, 8, 17]]}, "DOI": "10.1017/cbo9780511527098.002", "type": "book-chapter", "created": {"date-parts": [[2010, 2, 17]], "date-time": "2010-02-17T13:32:44Z", "timestamp": 1266413564000}, "page": "19-46", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Immunotherapy of bladder cancer"], "prefix": "10.1017", "author": [{"given": "Anton B.", "family": "Alexandroff", "sequence": "first", "affiliation": []}, {"given": "Keith", "family": "James", "sequence": "additional", "affiliation": []}], "member": "56", "container-title": ["Cancer Vaccines and Immunotherapy"], "link": [{"URL": "https://www.cambridge.org/core/services/aop-cambridge-core/content/view/A3F3E2F9AE23D12B9B7D80EF763AED5A", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T22:07:22Z", "timestamp": 1575324442000}, "score": 31.324768, "issued": {"date-parts": [[2000, 8, 17]]}, "ISBN": ["9780521622639", "9780511527098"], "references-count": 0, "URL": "http://dx.doi.org/10.1017/cbo9780511527098.002"}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T14:54:12Z", "timestamp": 1574693652125}, "reference-count": 0, "publisher": "Informa UK Limited", "license": [{"URL": "http://creativecommons.org/licenses/by-nc/3.0/", "start": {"date-parts": [[2015, 5, 1]], "date-time": "2015-05-01T00:00:00Z", "timestamp": 1430438400000}, "delay-in-days": 0, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["RRU"], "DOI": "10.2147/rru.s63447", "type": "journal-article", "created": {"date-parts": [[2015, 5, 15]], "date-time": "2015-05-15T03:55:16Z", "timestamp": 1431662116000}, "page": "65", "source": "Crossref", "is-referenced-by-count": 10, "title": ["Immunotherapy for bladder cancer"], "prefix": "10.2147", "author": [{"given": "James", "family": "Green", "sequence": "first", "affiliation": []}, {"given": "Oliver", "family": "Fuge", "sequence": "additional", "affiliation": []}, {"given": "Paula", "family": "Allchorne", "sequence": "additional", "affiliation": []}, {"given": "Nikhil", "family": "Vasdev", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2015, 5]]}, "container-title": ["Research and Reports in Urology"], "language": "en", "link": [{"URL": "https://www.dovepress.com/getfile.php?fileID=24898", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 10, 30]], "date-time": "2016-10-30T22:34:14Z", "timestamp": 1477866854000}, "score": 29.543089, "issued": {"date-parts": [[2015, 5]]}, "references-count": 0, "URL": "http://dx.doi.org/10.2147/rru.s63447", "ISSN": ["2253-2447"], "issn-type": [{"value": "2253-2447", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T09:36:16Z", "timestamp": 1575106576259}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1999, 11, 1]], "date-time": "1999-11-01T00:00:00Z", "timestamp": 941414400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The Journal of Urology"], "published-print": {"date-parts": [[1999, 11]]}, "DOI": "10.1097/00005392-199911000-00002", "type": "journal-article", "created": {"date-parts": [[2003, 11, 18]], "date-time": "2003-11-18T20:00:19Z", "timestamp": 1069185619000}, "page": "1581", "source": "Crossref", "is-referenced-by-count": 0, "title": ["IMMUNOTHERAPY OF BLADDER CANCER"], "prefix": "10.1097", "author": [{"given": "James", "family": "Kozlowski", "sequence": "first", "affiliation": []}], "member": "276", "container-title": ["The Journal of Urology"], "language": "en", "deposited": {"date-parts": [[2018, 12, 13]], "date-time": "2018-12-13T20:29:45Z", "timestamp": 1544732985000}, "score": 28.018986, "subtitle": [""], "issued": {"date-parts": [[1999, 11]]}, "references-count": 0, "URL": "http://dx.doi.org/10.1097/00005392-199911000-00002", "ISSN": ["0022-5347"], "issn-type": [{"value": "0022-5347", "type": "print"}], "subject": ["Urology"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T15:38:11Z", "timestamp": 1574177891672}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "5", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1999, 11, 1]], "date-time": "1999-11-01T00:00:00Z", "timestamp": 941414400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Urology"], "published-print": {"date-parts": [[1999, 11]]}, "DOI": "10.1016/s0022-5347(05)68170-0", "type": "journal-article", "created": {"date-parts": [[2006, 1, 17]], "date-time": "2006-01-17T21:55:41Z", "timestamp": 1137534941000}, "page": "1581-1581", "source": "Crossref", "is-referenced-by-count": 2, "title": ["IMMUNOTHERAPY OF BLADDER CANCER"], "prefix": "10.1097", "volume": "162", "author": [{"given": "James", "family": "Kozlowski", "sequence": "first", "affiliation": [{"name": "Department of Urology Northwestern University Chicago, Illinois"}]}], "member": "276", "container-title": ["Journal of Urology"], "language": "en", "link": [{"URL": "http://api.elsevier.com/content/article/PII:S0022534705681700?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://api.elsevier.com/content/article/PII:S0022534705681700?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 17]], "date-time": "2019-06-17T13:57:08Z", "timestamp": 1560779828000}, "score": 25.786028, "issued": {"date-parts": [[1999, 11]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1999, 11]]}, "issue": "5"}, "alternative-id": ["10.1016/S0022-5347(05)68170-0"], "URL": "http://dx.doi.org/10.1016/s0022-5347(05)68170-0", "ISSN": ["0022-5347", "1527-3792"], "issn-type": [{"value": "0022-5347", "type": "print"}, {"value": "1527-3792", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 29]], "date-time": "2019-11-29T18:27:18Z", "timestamp": 1575052038598}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Immunology, Immunotherapy"], "published-print": {"date-parts": [[1995, 2, 1]]}, "DOI": "10.1007/s002620050153", "type": "journal-article", "created": {"date-parts": [[2002, 8, 25]], "date-time": "2002-08-25T08:03:26Z", "timestamp": 1030262606000}, "page": "119-124", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Production of urinary tumour necrosis factors and soluble tumour necrosis factor receptors in bladder cancer patients after bacillus Calmette-Gu\ufffdrin immunotherapy"], "prefix": "10.1007", "volume": "40", "author": [{"given": "A. M.", "family": "Jackson", "sequence": "first", "affiliation": []}, {"given": "Anton B.", "family": "Alexandrov", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Prescott", "sequence": "additional", "affiliation": []}, {"given": "Keith", "family": "James", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Cancer Immunology, Immunotherapy"], "deposited": {"date-parts": [[2019, 11, 4]], "date-time": "2019-11-04T16:31:15Z", "timestamp": 1572885075000}, "score": 24.218752, "issued": {"date-parts": [[1995, 2, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1995, 2, 1]]}, "issue": "2"}, "alternative-id": ["BCE916DH9UMJ4W02"], "URL": "http://dx.doi.org/10.1007/s002620050153", "ISSN": ["0340-7004", "1432-0851"], "issn-type": [{"value": "0340-7004", "type": "print"}, {"value": "1432-0851", "type": "electronic"}], "subject": ["Immunology", "Immunology and Allergy", "Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T06:21:29Z", "timestamp": 1574144489391}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Immunotherapy"], "published-print": {"date-parts": [[2004, 11]]}, "DOI": "10.1097/00002371-200411000-00206", "type": "journal-article", "created": {"date-parts": [[2004, 11, 5]], "date-time": "2004-11-05T09:01:36Z", "timestamp": 1099645296000}, "page": "S58", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Gmp Manufacturing Process and Stability of Cryopreserved Activated Macrophages for Adjuvant Treatment of Superficial Bladder Cancer"], "prefix": "10.1097", "volume": "27", "author": [{"given": "Aurelie", "family": "Boyer", "sequence": "first", "affiliation": []}, {"given": "Paula", "family": "Doceur", "sequence": "additional", "affiliation": []}, {"given": "Christophe", "family": "Cambouris", "sequence": "additional", "affiliation": []}, {"given": "James", "family": "Bender", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Journal of Immunotherapy"], "language": "en", "deposited": {"date-parts": [[2011, 4, 23]], "date-time": "2011-04-23T20:00:49Z", "timestamp": 1303588849000}, "score": 23.748352, "subtitle": [""], "issued": {"date-parts": [[2004, 11]]}, "references-count": 0, "journal-issue": {"issue": "6"}, "URL": "http://dx.doi.org/10.1097/00002371-200411000-00206", "ISSN": ["1524-9557"], "issn-type": [{"value": "1524-9557", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T04:08:19Z", "timestamp": 1574741299742}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "S2", "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["j. immunotherapy cancer"], "published-print": {"date-parts": [[2015, 12]]}, "DOI": "10.1186/2051-1426-3-s2-p222", "type": "journal-article", "created": {"date-parts": [[2015, 11, 5]], "date-time": "2015-11-05T05:02:56Z", "timestamp": 1446699776000}, "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["A monocyte and interferon based cell therapy for the treatment of ovarian cancer"], "prefix": "10.1186", "volume": "3", "author": [{"given": "Daniel", "family": "Green", "sequence": "first", "affiliation": []}, {"given": "Chase", "family": "Johnson", "sequence": "additional", "affiliation": []}, {"given": "Kathryn", "family": "Zoon", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2015, 11, 4]]}, "container-title": ["Journal for ImmunoTherapy of Cancer"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1186/2051-1426-3-S2-P222.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 1, 22]], "date-time": "2019-01-22T07:20:09Z", "timestamp": 1548141609000}, "score": 22.852869, "issued": {"date-parts": [[2015, 11, 4]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2015, 12]]}, "issue": "S2"}, "alternative-id": ["988"], "URL": "http://dx.doi.org/10.1186/2051-1426-3-s2-p222", "ISSN": ["2051-1426"], "issn-type": [{"value": "2051-1426", "type": "electronic"}], "assertion": [{"value": "4 November 2015", "order": 1, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}], "article-number": "P222"}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T06:20:58Z", "timestamp": 1574749258350}, "reference-count": 11, "publisher": "Wiley", "issue": "5", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer"], "published-print": {"date-parts": [[2016, 3, 1]]}, "DOI": "10.1002/cncr.29825", "type": "journal-article", "created": {"date-parts": [[2015, 12, 10]], "date-time": "2015-12-10T02:05:32Z", "timestamp": 1449713132000}, "page": "676-677", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Genomic profiling of advanced bladder cancer to guide the use of targeted therapeutics"], "prefix": "10.1002", "volume": "122", "author": [{"given": "Angela K.", "family": "Green", "sequence": "first", "affiliation": [{"name": "Division of Hematology/Oncology, Department of Medicine; University of North Carolina Lineberger Comprehensive Cancer Center; Chapel Hill North Carolina"}]}, {"given": "Matthew I.", "family": "Milowsky", "sequence": "additional", "affiliation": [{"name": "Division of Hematology/Oncology, Department of Medicine; University of North Carolina Lineberger Comprehensive Cancer Center; Chapel Hill North Carolina"}]}], "member": "311", "published-online": {"date-parts": [[2015, 12, 9]]}, "reference": [{"key": "10.1002/cncr.29825-BIB0001|cncr29825-cit-0001", "unstructured": "National Cancer Institute SEER stat fact sheets: bladder cancer http://seer.cancer.gov/statfacts/html/urinb.html 2015"}, {"key": "10.1002/cncr.29825-BIB0002|cncr29825-cit-0002", "doi-asserted-by": "crossref", "first-page": "315", "DOI": "10.1038/nature12965", "article-title": "Comprehensive molecular characterization of urothelial bladder carcinoma", "volume": "507", "author": "Cancer Genome Atlas Research Network", "year": "2014", "journal-title": "Nature."}, {"key": "10.1002/cncr.29825-BIB0003|cncr29825-cit-0003", "doi-asserted-by": "crossref", "first-page": "702", "DOI": "10.1002/cncr.29826", "article-title": "Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterations", "volume": "122", "author": "Ross", "year": "2016", "journal-title": "Cancer."}, {"key": "10.1002/cncr.29825-BIB0004|cncr29825-cit-0004", "doi-asserted-by": "crossref", "first-page": "462", "DOI": "10.1111/j.1464-410X.2012.11720.x", "article-title": "Phase II study of everolimus in metastatic urothelial cancer", "volume": "112", "author": "Milowsky", "year": "2013", "journal-title": "BJU Int."}, {"key": "10.1002/cncr.29825-BIB0005|cncr29825-cit-0005", "doi-asserted-by": "crossref", "first-page": "221", "DOI": "10.1126/science.1226344", "article-title": "Genome sequencing identifies a basis for everolimus sensitivity", "volume": "338", "author": "Iyer", "year": "2012", "journal-title": "Science."}, {"key": "10.1002/cncr.29825-BIB0006|cncr29825-cit-0006", "doi-asserted-by": "crossref", "first-page": "3133", "DOI": "10.1200/JCO.2012.46.5740", "article-title": "Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer", "volume": "31", "author": "Iyer", "year": "2013", "journal-title": "J Clin Oncol."}, {"key": "10.1002/cncr.29825-BIB0007|cncr29825-cit-0007", "doi-asserted-by": "crossref", "first-page": "1694", "DOI": "10.1056/NEJMoa1210093", "article-title": "Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations", "volume": "367", "author": "Flaherty", "year": "2012", "journal-title": "N Engl J Med."}, {"key": "10.1002/cncr.29825-BIB0008|cncr29825-cit-0008", "doi-asserted-by": "crossref", "first-page": "2725", "DOI": "10.1200/JCO.2015.61.9296", "article-title": "Tumor genetic screening programs: a call to action", "volume": "33", "author": "Hyman", "year": "2015", "journal-title": "J Clin Oncol."}, {"key": "10.1002/cncr.29825-BIB0009|cncr29825-cit-0009", "doi-asserted-by": "crossref", "first-page": "2753", "DOI": "10.1200/JCO.2014.60.4165", "article-title": "Feasibility of large-scale genomic testing to facilitate enrollment onto genomically matched clinical trials", "volume": "33", "author": "Meric-Bernstam", "year": "2015", "journal-title": "J Clin Oncol."}, {"key": "10.1002/cncr.29825-BIB0010|cncr29825-cit-0010", "doi-asserted-by": "crossref", "first-page": "1317", "DOI": "10.1200/JCO.2013.52.4298", "article-title": "Physicians' attitudes about multiplex tumor genomic testing", "volume": "32", "author": "Gray", "year": "2014", "journal-title": "J Clin Oncol."}, {"key": "10.1002/cncr.29825-BIB0011|cncr29825-cit-0011", "unstructured": "Smith M BCAN launches cancer genomics consortium [press release] http://www.bcan.org/press-release-bcgc/ 2015"}], "container-title": ["Cancer"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.29825", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 24]], "date-time": "2017-06-24T01:16:52Z", "timestamp": 1498267012000}, "score": 22.580605, "subtitle": ["Genomic Profiling for Bladder Cancer"], "issued": {"date-parts": [[2015, 12, 9]]}, "references-count": 11, "journal-issue": {"published-print": {"date-parts": [[2016, 3, 1]]}, "issue": "5"}, "URL": "http://dx.doi.org/10.1002/cncr.29825", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0008-543X"], "issn-type": [{"value": "0008-543X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T20:09:14Z", "timestamp": 1575144554240}, "reference-count": 31, "publisher": "Springer Science and Business Media LLC", "issue": "2", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1995, 3, 1]], "date-time": "1995-03-01T00:00:00Z", "timestamp": 794016000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Immunol Immunother"], "published-print": {"date-parts": [[1995, 3]]}, "DOI": "10.1007/bf01520294", "type": "journal-article", "created": {"date-parts": [[2005, 4, 18]], "date-time": "2005-04-18T23:15:50Z", "timestamp": 1113866150000}, "page": "119-124", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Production of urinary tumour necrosis factors and soluble tumour necrosis factor receptors in bladder cancer patients afterbacillus Calmette-Guerin immunotherapy"], "prefix": "10.1007", "volume": "40", "author": [{"given": "Andrew M.", "family": "Jackson", "sequence": "first", "affiliation": []}, {"given": "Anton B.", "family": "Alexandrov", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Prescott", "sequence": "additional", "affiliation": []}, {"given": "Keith", "family": "James", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "CR1", "first-page": "499", "volume": "19", "author": "DL Lamm", "year": "1992", "unstructured": "Lamm DL (1992) Carcinoma in situ. Urol Clin N Am 19:499?508", "journal-title": "Urol Clin N Am"}, {"key": "CR2", "doi-asserted-by": "crossref", "first-page": "1450", "DOI": "10.1200/JCO.1988.6.9.1450", "volume": "6", "author": "HW Herr", "year": "1988", "unstructured": "Herr HW, Laudone VP, Badalement RA, Oettgen HF, Sogani PC, Freedman BD, et al (1988) Bacillus Calmette-Gu\u00e9rin therapy alters the progression of superficial bladder cancer. J Clin Oncol (1986) 6:1450?1455", "journal-title": "J Clin Oncol"}, {"key": "CR3", "doi-asserted-by": "crossref", "first-page": "375", "DOI": "10.1016/0090-1229(86)90043-7", "volume": "40", "author": "TL Ratliff", "year": "1986", "unstructured": "Ratliff TL, Haaf EO, Catalona WJ (1986) Interleukin-2 production during intravesical bacille Calmette-Gu\u00e9rin therapy for bladder cancer. Clin Immunol Immunopathol 40:375?379", "journal-title": "Clin Immunol Immunopathol"}, {"key": "CR4", "doi-asserted-by": "crossref", "first-page": "1447", "DOI": "10.1002/1097-0142(19891001)64:7<1447::AID-CNCR2820640715>3.0.CO;2-Y", "volume": "64", "author": "JD Fleischmann", "year": "1989", "unstructured": "Fleischmann JD, Toossi Z, Ellner JJ, Wentworth DB, Ratliff TL, Imbembo AI (1989) Urinary interleukins in patients receiving intravesical bacillus Calmette-Gu\u00e9rin therapy for superficial bladder cancer. Cancer 64:1447?1454", "journal-title": "Cancer"}, {"key": "CR5", "doi-asserted-by": "crossref", "first-page": "182", "DOI": "10.1007/BF01744734", "volume": "31", "author": "WH Jong De", "year": "1990", "unstructured": "De Jong WH, De Boer EC, Van der Meijden AP, Vegt P, Steerenberg PA, Debruyne FM, Ruitenberg EJ (1990) Presence of interleukin-2 in urine of superficial bladder cancer patients after intravesical treatment with bacillus Calmette-Gu\u00e9rin. Cancer Immunol Immunother 31:182?186", "journal-title": "Cancer Immunol Immunother"}, {"key": "CR6", "doi-asserted-by": "crossref", "first-page": "1248", "DOI": "10.1016/S0022-5347(17)39713-6", "volume": "144", "author": "S Prescott", "year": "1990", "unstructured": "Prescott S, James K, Hargreave TB, Chisholm GD (1990) Radioimmunoassay detection of interferon-gamma in urine after intravesical BCG therapy. J Urol 144:1248?1240", "journal-title": "J Urol"}, {"key": "CR7", "doi-asserted-by": "crossref", "first-page": "171", "DOI": "10.1159/000473608", "volume": "19", "author": "M Bettex-Galland", "year": "1991", "unstructured": "Bettex-Galland M, Studer UE, Walz A, Dewald B, Baggiolini M (1991) Neutrophil-activating peptide-1/interleukin-8 detection in human urine during acute bladder inflammation caused by transurethral resection of superficial cancer and bacillus Calmette-Gu\u00e9rin. Eur Urol 19:171?175", "journal-title": "Eur Urol"}, {"key": "CR8", "doi-asserted-by": "crossref", "first-page": "306", "DOI": "10.1007/BF01741551", "volume": "34", "author": "EC Boer De", "year": "1992", "unstructured": "De Boer EC, De Jong WH, Steerenberg PA, Aarden LA, Tettroo E, De Groot ER, Van der Meijden AP, Vegt PD, Debruyne FM, Ruitenberg EJ (1992) Induction of interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Gu\u00e9rin in superficial bladder cancer. Cancer Immunol Immunother 34:306?312", "journal-title": "Cancer Immunol Immunother"}, {"key": "CR9", "unstructured": "Jackson AM, Alexandroff AB, Kelly RW, Skibinska A, Esuvaranathan K, Prescott S, Chisholm GD, James K (1994) Changes in urinary cytokines and soluble intercellular adhesion molecule-1 in bladder cancer patients after bacillus Calmette-Gu\u00e9rin immunotherapy. Clin Exp Immunol (in press)"}, {"key": "CR10", "doi-asserted-by": "crossref", "first-page": "25", "DOI": "10.1007/BF01789127", "volume": "36", "author": "AM Jackson", "year": "1993", "unstructured": "Jackson AM, Hawkyard SJ, Prescott S, James K, Chisholm GD (1993) The immunomodulatory effects of urine from patients with superficial bladder cancer receiving intravesical Evans BCG therapy. Cancer Immunol Immunother 36:25?30", "journal-title": "Cancer Immunol Immunother"}, {"key": "CR11", "doi-asserted-by": "crossref", "first-page": "921", "DOI": "10.1002/ijc.2910550608", "volume": "55", "author": "AM Jackson", "year": "1993", "unstructured": "Jackson AM, Alexandroff AB, Gribbon SC, Esuvaranathan K, James K (1993) Expression and shedding of ICAM-1 in bladder cancer and its immunotherapy. Int J Cancer 55:921?925", "journal-title": "Int J Cancer"}, {"key": "CR12", "unstructured": "Jackson AM (1992) Cytokines, cell adhesion molecules and bladder cancer immunotherapy. PhD thesis, University of Edinburgh"}, {"key": "CR13", "doi-asserted-by": "crossref", "first-page": "1399", "DOI": "10.1016/S0022-5347(17)37582-1", "volume": "147", "author": "SJ Hawkyard", "year": "1992", "unstructured": "Hawkyard SJ, Jackson AM, James K, Prescott S, Smyth JF, Chisholm GD (1992) The inhibitory effects of interferon-gamma on the growth of bladder cancer cells. J Urol 147:1399?1403", "journal-title": "J Urol"}, {"key": "CR14", "first-page": "697", "volume": "5", "author": "AM Jackson", "year": "1994", "unstructured": "Jackson AM, Alexandroff AB, Fleming D, Prescott S, Chisholm GD, James K (1994) Bacillus Calmette-Gu\u00e9rin (BCG) organisms directly alter the growth of bladder tumour cells. Int J Oncol 5:697?703", "journal-title": "Int J Oncol"}, {"key": "CR15", "doi-asserted-by": "crossref", "first-page": "1078", "DOI": "10.1016/S0022-5347(17)38538-5", "volume": "145", "author": "SJ Hawkyard", "year": "1991", "unstructured": "Hawkyard SJ, James K, Prescott S, Jackson AM, Ritchie AWS, Smyth JF, Chisholm GD (1991) The effects of recombinant human interferon-gamma on a panel of human bladder cancer cell lines. J Urol 145:1078?1081", "journal-title": "J Urol"}, {"key": "CR16", "first-page": "286", "volume": "76", "author": "AM Jackson", "year": "1992", "unstructured": "Jackson AM, Alexandroff AB, Prescott S, James K, Chisholm GD (1992) Role of adhesion molecules in lymphokine activated killer cell killing of bladder cancer cells: Further evidence for a third ligand for leucocyte function associated antigen-1. Immunology 76:286?291", "journal-title": "Immunology"}, {"key": "CR17", "doi-asserted-by": "crossref", "first-page": "1583", "DOI": "10.1016/S0022-5347(17)36974-4", "volume": "148", "author": "AM Jackson", "year": "1992", "unstructured": "Jackson AM, Alexandroff AB, Prescott S, James K, Chisholm GD (1992) Adhesion molecules on bladder cancer cells: modulation by interferon-gamma and tumour necrosis factor-alpha. J Urol 148:1583?1586", "journal-title": "J Urol"}, {"key": "CR18", "doi-asserted-by": "crossref", "first-page": "117", "DOI": "10.1016/0165-2478(94)90182-1", "volume": "40", "author": "AB Alexandroff", "year": "1994", "unstructured": "Alexandroff AB, Jackson AM, Esuvaranathan K, Prescott S, James K (1994) Autocrine regulation of ICAM-1 expression on bladder cancer cell lines: evidence for role of IL-1 alpha. Immunol Lett 40:117?124", "journal-title": "Immunol Lett"}, {"key": "CR19", "doi-asserted-by": "crossref", "first-page": "1385", "DOI": "10.1016/S0022-5347(17)35265-5", "volume": "151", "author": "SC Campbell", "year": "1994", "unstructured": "Campbell SC, Tanabe K, Alexander JP, Eidinger M, Tubbs RR, Klein EA (1994) Intercellular adhesion molecule-1 expression by bladder cancer cells: functional effects. J Urol 151:1385?1390", "journal-title": "J Urol"}, {"key": "CR20", "doi-asserted-by": "crossref", "first-page": "625", "DOI": "10.1146/annurev.iy.07.040189.003205", "volume": "7", "author": "B Beutler", "year": "1989", "unstructured": "Beutler B, Cerami A (1989) The biology of cachectin/TNF?a primary mediator of the host response. Annu Rev Immunol 7:625?655", "journal-title": "Annu Rev Immunol"}, {"key": "CR21", "doi-asserted-by": "crossref", "first-page": "264", "DOI": "10.1111/j.1464-410X.1989.tb05187.x", "volume": "63", "author": "S Prescott", "year": "1989", "unstructured": "Prescott S, James K, Busutill A, Hargreave TB, Chisholm GD, Symth JF (1989) HLA-DR expression by high grade superficial bladder cancer treated with BCG. Br J Urol 63:264?269", "journal-title": "Br J Urol"}, {"key": "CR22", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.1136/jcp.47.4.309", "volume": "47", "author": "AM Jackson", "year": "1994", "unstructured": "Jackson AM, Alexandroff AB, McIntyre M, Esuvaranathan K, James K, Chisholm GD (1994) BCG immunotherapy induces ICAM-1 expression on bladder tumours. J Clin Pathol 47:309?312", "journal-title": "J Clin Pathol"}, {"key": "CR23", "first-page": "4286", "volume": "52", "author": "EC Lattime", "year": "1992", "unstructured": "Lattime EC, Gomella LG, McCue PA (1992) Murine bladder carcinoma cells present antigen to BCG-specific CD4+ T-cells. Cancer Res 52:4286?4290", "journal-title": "Cancer Res"}, {"key": "CR24", "doi-asserted-by": "crossref", "first-page": "151", "DOI": "10.1016/0167-5699(92)90116-O", "volume": "13", "author": "LA Tartaglia", "year": "1992", "unstructured": "Tartaglia LA, Goeddel DV (1992) Two TNF receptors. Immunol Today 13:151?153", "journal-title": "Immunol Today"}, {"key": "CR25", "first-page": "11966", "volume": "264", "author": "P Seckinger", "year": "1989", "unstructured": "Seckinger P, Isaaz S, Dayer J-M (1989) Purification and biologic characterisation of a specific tumour necrosis factor-alpha inhibitor. J Biol Chem 264:11966?11973", "journal-title": "J Biol Chem"}, {"key": "CR26", "doi-asserted-by": "crossref", "first-page": "270", "DOI": "10.1111/j.1600-0609.1989.tb00111.x", "volume": "42", "author": "I Olsson", "year": "1989", "unstructured": "Olsson I, Lantz M, Nilsson E, Peetre C, Thysell H, Grubb A, Adolf G (1989) Two tumour necrosis factor-binding proteins purified from human urine. Eur J Haematol 42:270?275", "journal-title": "Eur J Haematol"}, {"key": "CR27", "first-page": "1531", "volume": "265", "author": "H Engelmann", "year": "1990", "unstructured": "Engelmann H, Novick D, Wallach D (1990) Isolation and characterisation of tumour necrosis factor binding protein from urine. J Biol Chem 265:1531?1536", "journal-title": "J Biol Chem"}, {"key": "CR28", "unstructured": "Quantikine human sTNF RII assay manual. DRT200. R&D Systems Europe, Abingdon"}, {"key": "CR29", "first-page": "3516", "volume": "54", "author": "S Saito", "year": "1994", "unstructured": "Saito S, Bannerji R, Gansbacher B, Rosenthal F, Romanenko P, Heston W, Fair W, Gilboa E (1994) Immunotherapy of bladder cancer with cytokine gene-modified tumour vaccines. Cancer Res 54:3516?3520", "journal-title": "Cancer Res"}, {"key": "CR30", "doi-asserted-by": "crossref", "first-page": "216", "DOI": "10.1016/S0022-5347(17)43958-9", "volume": "137", "author": "PA Merguerian", "year": "1987", "unstructured": "Merguerian PA, Donahue L, Cocket TK (1987) Intraluminal interleukin-2 and bacillus Calmette-Gu\u00e9rin for treatment of bladder cancer: a preliminary report. J Urol 137:216?219", "journal-title": "J Urol"}, {"key": "CR31", "first-page": "432", "volume": "53", "author": "RTD Oliver", "year": "1986", "unstructured": "Oliver RTD, Waxman JH, Kwok H, Fowler CG, Mathewman P, Blandy JP (1986) Alpha lymphoblastoid interferon for noninvasive bladder cancer. Br J Cancer 53:432", "journal-title": "Br J Cancer"}], "container-title": ["Cancer Immunology Immunotherapy"], "language": "en", "link": [{"URL": "http://link.springer.com/article/10.1007/BF01520294/fulltext.html", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/BF01520294.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/BF01520294/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/BF01520294", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 3]], "date-time": "2019-05-03T13:02:29Z", "timestamp": 1556888549000}, "score": 22.512026, "issued": {"date-parts": [[1995, 3]]}, "references-count": 31, "journal-issue": {"published-print": {"date-parts": [[1995, 3]]}, "issue": "2"}, "alternative-id": ["BF01520294"], "URL": "http://dx.doi.org/10.1007/bf01520294", "relation": {"cites": []}, "ISSN": ["0340-7004", "1432-0851"], "issn-type": [{"value": "0340-7004", "type": "print"}, {"value": "1432-0851", "type": "electronic"}], "subject": ["Immunology", "Immunology and Allergy", "Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T10:37:13Z", "timestamp": 1574419033900}, "reference-count": 59, "publisher": "Springer Science and Business Media LLC", "issue": "2", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2011, 11, 16]], "date-time": "2011-11-16T00:00:00Z", "timestamp": 1321401600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Immunol Immunother"], "published-print": {"date-parts": [[2012, 2]]}, "DOI": "10.1007/s00262-011-1139-7", "type": "journal-article", "created": {"date-parts": [[2011, 11, 15]], "date-time": "2011-11-15T11:07:20Z", "timestamp": 1321355240000}, "page": "231-237", "source": "Crossref", "is-referenced-by-count": 18, "title": ["MicroRNA regulation in cancer-associated fibroblasts"], "prefix": "10.1007", "volume": "61", "author": [{"given": "Olga", "family": "Aprelikova", "sequence": "first", "affiliation": []}, {"given": "Jeffrey E.", "family": "Green", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2011, 11, 16]]}, "reference": [{"key": "1139_CR1", "doi-asserted-by": "crossref", "first-page": "46", "DOI": "10.1038/35094059", "volume": "1", "author": "MJ Bissell", "year": "2001", "unstructured": "Bissell MJ, Radisky D (2001) Putting tumours in context. Nat Rev Cancer 1:46\u201354", "journal-title": "Nat Rev Cancer"}, {"key": "1139_CR2", "doi-asserted-by": "crossref", "first-page": "392", "DOI": "10.1038/nrc1877", "volume": "6", "author": "R Kalluri", "year": "2006", "unstructured": "Kalluri R, Zeisberg M (2006) Fibroblasts in cancer. Nat Rev Cancer 6:392\u2013401", "journal-title": "Nat Rev Cancer"}, {"key": "1139_CR3", "doi-asserted-by": "crossref", "first-page": "30", "DOI": "10.1016/j.tig.2008.10.012", "volume": "25", "author": "K Polyak", "year": "2009", "unstructured": "Polyak K, Haviv I, Campbell IG (2009) Co-evolution of tumor cells and their microenvironment. Trends Genet 25:30\u201338", "journal-title": "Trends Genet"}, {"key": "1139_CR4", "doi-asserted-by": "crossref", "first-page": "5706", "DOI": "10.1158/0008-5472.CAN-09-2356", "volume": "70", "author": "D Barkan", "year": "2010", "unstructured": "Barkan D, El Touny LH, Michalowski AM, Smith JA, Chu I, Davis AS, Webster JD, Hoover S, Simpson RM, Gauldie J, Green JE (2010) Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment. Cancer Res 70:5706\u20135716", "journal-title": "Cancer Res"}, {"key": "1139_CR5", "doi-asserted-by": "crossref", "first-page": "6241", "DOI": "10.1158/0008-5472.CAN-07-6849", "volume": "68", "author": "D Barkan", "year": "2008", "unstructured": "Barkan D, Kleinman H, Simmons JL, Asmussen H, Kamaraju AK, Hoenorhoff MJ, Liu ZY, Costes SV, Cho EH, Lockett S, Khanna C, Chambers AF, Green JE (2008) Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res 68:6241\u20136250", "journal-title": "Cancer Res"}, {"key": "1139_CR6", "doi-asserted-by": "crossref", "first-page": "834", "DOI": "10.1038/nrc2256", "volume": "7", "author": "JA Aguirre-Ghiso", "year": "2007", "unstructured": "Aguirre-Ghiso JA (2007) Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 7:834\u2013846", "journal-title": "Nat Rev Cancer"}, {"key": "1139_CR7", "doi-asserted-by": "crossref", "first-page": "159", "DOI": "10.1016/S0065-230X(08)00006-7", "volume": "100", "author": "H Rubin", "year": "2008", "unstructured": "Rubin H (2008) Contact interactions between cells that suppress neoplastic development: can they also explain metastatic dormancy? Adv Cancer Res 100:159\u2013202", "journal-title": "Adv Cancer Res"}, {"key": "1139_CR8", "doi-asserted-by": "crossref", "first-page": "335", "DOI": "10.1016/j.cell.2005.02.034", "volume": "121", "author": "A Orimo", "year": "2005", "unstructured": "Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121:335\u2013348", "journal-title": "Cell"}, {"key": "1139_CR9", "doi-asserted-by": "crossref", "first-page": "3155", "DOI": "10.1172/JCI33295", "volume": "117", "author": "K Polyak", "year": "2007", "unstructured": "Polyak K (2007) Breast cancer: origins and evolution. J Clin Invest 117:3155\u20133163", "journal-title": "J Clin Invest"}, {"key": "1139_CR10", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1146/annurev.pathol.1.110304.100224", "volume": "1", "author": "TD Tlsty", "year": "2006", "unstructured": "Tlsty TD, Coussens LM (2006) Tumor stroma and regulation of cancer development. Annu Rev Pathol 1:119\u2013150", "journal-title": "Annu Rev Pathol"}, {"key": "1139_CR11", "doi-asserted-by": "crossref", "first-page": "830", "DOI": "10.1002/jcb.21186", "volume": "101", "author": "DC Radisky", "year": "2007", "unstructured": "Radisky DC, Kenny PA, Bissell MJ (2007) Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT? J Cell Biochem 101:830\u2013839", "journal-title": "J Cell Biochem"}, {"key": "1139_CR12", "first-page": "829", "volume": "126", "author": "PA Adegboyega", "year": "2002", "unstructured": "Adegboyega PA, Mifflin RC, DiMari JF, Saada JI, Powell DW (2002) Immunohistochemical study of myofibroblasts in normal colonic mucosa, hyperplastic polyps, and adenomatous colorectal polyps. Arch Pathol Lab Med 126:829\u2013836", "journal-title": "Arch Pathol Lab Med"}, {"key": "1139_CR13", "doi-asserted-by": "crossref", "first-page": "429", "DOI": "10.1002/path.1398", "volume": "200", "author": "O Wever De", "year": "2003", "unstructured": "De Wever O, Mareel M (2003) Role of tissue stroma in cancer cell invasion. J Pathol 200:429\u2013447", "journal-title": "J Pathol"}, {"key": "1139_CR14", "doi-asserted-by": "crossref", "first-page": "194", "DOI": "10.1016/j.cyto.2008.05.012", "volume": "43", "author": "LA Begley", "year": "2008", "unstructured": "Begley LA, Kasina S, MacDonald J, Macoska JA (2008) The inflammatory microenvironment of the aging prostate facilitates cellular proliferation and hypertrophy. Cytokine 43:194\u2013199", "journal-title": "Cytokine"}, {"key": "1139_CR15", "doi-asserted-by": "crossref", "first-page": "848", "DOI": "10.1126/science.1090922", "volume": "303", "author": "NA Bhowmick", "year": "2004", "unstructured": "Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, Washington MK, Neilson EG, Moses HL (2004) TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303:848\u2013851", "journal-title": "Science"}, {"key": "1139_CR16", "doi-asserted-by": "crossref", "first-page": "1084", "DOI": "10.1038/nature08486", "volume": "461", "author": "AJ Trimboli", "year": "2009", "unstructured": "Trimboli AJ, Cantemir-Stone CZ, Li F, Wallace JA, Merchant A, Creasap N, Thompson JC, Caserta E, Wang H, Chong JL, Naidu S, Wei G, Sharma SM, Stephens JA, Fernandez SA, Gurcan MN, Weinstein MB, Barsky SH, Yee L, Rosol TJ, Stromberg PC, Robinson ML, Pepin F, Hallett M, Park M, Ostrowski MC, Leone G (2009) Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature 461:1084\u20131091", "journal-title": "Nature"}, {"key": "1139_CR17", "doi-asserted-by": "crossref", "first-page": "17", "DOI": "10.1016/j.ccr.2004.06.010", "volume": "6", "author": "M Allinen", "year": "2004", "unstructured": "Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, Porter D, Hu M, Chin L, Richardson A, Schnitt S, Sellers WR, Polyak K (2004) Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6:17\u201332", "journal-title": "Cancer Cell"}, {"key": "1139_CR18", "first-page": "5002", "volume": "59", "author": "AF Olumi", "year": "1999", "unstructured": "Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR (1999) Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59:5002\u20135011", "journal-title": "Cancer Res"}, {"key": "1139_CR19", "doi-asserted-by": "crossref", "first-page": "e19", "DOI": "10.1371/journal.pmed.0050019", "volume": "5", "author": "K Pietras", "year": "2008", "unstructured": "Pietras K, Pahler J, Bergers G, Hanahan D (2008) Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting. PLoS Med 5:e19", "journal-title": "PLoS Med"}, {"key": "1139_CR20", "first-page": "174", "volume": "39", "author": "A Cardone", "year": "1997", "unstructured": "Cardone A, Tolino A, Zarcone R, Borruto Caracciolo G, Tartaglia E (1997) Prognostic value of desmoplastic reaction and lymphocytic infiltration in the management of breast cancer. Panminerva Med 39:174\u2013177", "journal-title": "Panminerva Med"}, {"key": "1139_CR21", "doi-asserted-by": "crossref", "first-page": "509", "DOI": "10.1016/j.oraloncology.2007.07.001", "volume": "44", "author": "MG Kellermann", "year": "2008", "unstructured": "Kellermann MG, Sobral LM, da Silva SD, Zecchin KG, Graner E, Lopes MA, Kowalski LP, Coletta RD (2008) Mutual paracrine effects of oral squamous cell carcinoma cells and normal oral fibroblasts: induction of fibroblast to myofibroblast transdifferentiation and modulation of tumor cell proliferation. Oral Oncol 44:509\u2013517", "journal-title": "Oral Oncol"}, {"key": "1139_CR22", "doi-asserted-by": "crossref", "first-page": "509", "DOI": "10.1387/ijdb.041802ad", "volume": "48", "author": "A Desmouliere", "year": "2004", "unstructured": "Desmouliere A, Guyot C, Gabbiani G (2004) The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. Int J Dev Biol 48:509\u2013517", "journal-title": "Int J Dev Biol"}, {"issue": "Suppl 2", "key": "1139_CR23", "doi-asserted-by": "crossref", "first-page": "S163", "DOI": "10.1016/j.lungcan.2004.07.977", "volume": "45", "author": "P Micke", "year": "2004", "unstructured": "Micke P, Ostman A (2004) Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy? Lung Cancer 45(Suppl 2):S163\u2013S175", "journal-title": "Lung Cancer"}, {"key": "1139_CR24", "doi-asserted-by": "crossref", "first-page": "1640", "DOI": "10.4161/cbt.5.12.3354", "volume": "5", "author": "H Sugimoto", "year": "2006", "unstructured": "Sugimoto H, Mundel TM, Kieran MW, Kalluri R (2006) Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol Ther 5:1640\u20131646", "journal-title": "Cancer Biol Ther"}, {"key": "1139_CR25", "doi-asserted-by": "crossref", "first-page": "8492", "DOI": "10.1158/0008-5472.CAN-04-1708", "volume": "64", "author": "NC Direkze", "year": "2004", "unstructured": "Direkze NC, Hodivala-Dilke K, Jeffery R, Hunt T, Poulsom R, Oukrif D, Alison MR, Wright NA (2004) Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res 64:8492\u20138495", "journal-title": "Cancer Res"}, {"key": "1139_CR26", "doi-asserted-by": "crossref", "first-page": "232", "DOI": "10.1016/S0006-291X(03)01544-4", "volume": "309", "author": "G Ishii", "year": "2003", "unstructured": "Ishii G, Sangai T, Oda T, Aoyagi Y, Hasebe T, Kanomata N, Endoh Y, Okumura C, Okuhara Y, Magae J, Emura M, Ochiya T, Ochiai A (2003) Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction. Biochem Biophys Res Commun 309:232\u2013240", "journal-title": "Biochem Biophys Res Commun"}, {"key": "1139_CR27", "doi-asserted-by": "crossref", "first-page": "557", "DOI": "10.1038/nature06188", "volume": "449", "author": "AE Karnoub", "year": "2007", "unstructured": "Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449:557\u2013563", "journal-title": "Nature"}, {"key": "1139_CR28", "doi-asserted-by": "crossref", "first-page": "116", "DOI": "10.1002/mc.20024", "volume": "40", "author": "E Rosenthal", "year": "2004", "unstructured": "Rosenthal E, McCrory A, Talbert M, Young G, Murphy-Ullrich J, Gladson C (2004) Elevated expression of TGF-beta1 in head and neck cancer-associated fibroblasts. Mol Carcinog 40:116\u2013121", "journal-title": "Mol Carcinog"}, {"key": "1139_CR29", "doi-asserted-by": "crossref", "first-page": "213", "DOI": "10.1002/ijc.20388", "volume": "112", "author": "IF San Francisco", "year": "2004", "unstructured": "San Francisco IF, DeWolf WC, Peehl DM, Olumi AF (2004) Expression of transforming growth factor-beta 1 and growth in soft agar differentiate prostate carcinoma-associated fibroblasts from normal prostate fibroblasts. Int J Cancer 112:213\u2013218", "journal-title": "Int J Cancer"}, {"key": "1139_CR30", "doi-asserted-by": "crossref", "first-page": "19", "DOI": "10.1016/j.semcdb.2009.10.002", "volume": "21", "author": "M Shimoda", "year": "2010", "unstructured": "Shimoda M, Mellody KT, Orimo A (2010) Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression. Semin Cell Dev Biol 21:19\u201325", "journal-title": "Semin Cell Dev Biol"}, {"key": "1139_CR31", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1016/j.ccr.2009.12.041", "volume": "17", "author": "N Erez", "year": "2010", "unstructured": "Erez N, Truitt M, Olson P, Arron ST, Hanahan D (2010) Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell 17:135\u2013147", "journal-title": "Cancer Cell"}, {"key": "1139_CR32", "doi-asserted-by": "crossref", "first-page": "7231", "DOI": "10.1158/0008-5472.CAN-04-2866", "volume": "64", "author": "K Fukino", "year": "2004", "unstructured": "Fukino K, Shen L, Matsumoto S, Morrison CD, Mutter GL, Eng C (2004) Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets. Cancer Res 64:7231\u20137236", "journal-title": "Cancer Res"}, {"key": "1139_CR33", "doi-asserted-by": "crossref", "first-page": "1001", "DOI": "10.1016/j.cell.2005.09.030", "volume": "123", "author": "R Hill", "year": "2005", "unstructured": "Hill R, Song Y, Cardiff RD, Van Dyke T (2005) Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell 123:1001\u20131011", "journal-title": "Cell"}, {"key": "1139_CR34", "doi-asserted-by": "crossref", "first-page": "355", "DOI": "10.1038/ng1013", "volume": "32", "author": "K Kurose", "year": "2002", "unstructured": "Kurose K, Gilley K, Matsumoto S, Watson PH, Zhou XP, Eng C (2002) Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat Genet 32:355\u2013357", "journal-title": "Nat Genet"}, {"key": "1139_CR35", "first-page": "2562", "volume": "60", "author": "F Moinfar", "year": "2000", "unstructured": "Moinfar F, Man YG, Arnould L, Bratthauer GL, Ratschek M, Tavassoli FA (2000) Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res 60:2562\u20132566", "journal-title": "Cancer Res"}, {"key": "1139_CR36", "doi-asserted-by": "crossref", "first-page": "88", "DOI": "10.1038/379088a0", "volume": "379", "author": "TG Graeber", "year": "1996", "unstructured": "Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, Giaccia AJ (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379:88\u201391", "journal-title": "Nature"}, {"key": "1139_CR37", "doi-asserted-by": "crossref", "first-page": "650", "DOI": "10.1038/ng.117", "volume": "40", "author": "W Qiu", "year": "2008", "unstructured": "Qiu W, Hu M, Sridhar A, Opeskin K, Fox S, Shipitsin M, Trivett M, Thompson ER, Ramakrishna M, Gorringe KL, Polyak K, Haviv I, Campbell IG (2008) No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas. Nat Genet 40:650\u2013655", "journal-title": "Nat Genet"}, {"key": "1139_CR38", "doi-asserted-by": "crossref", "first-page": "882", "DOI": "10.4161/cbt.7.6.5869", "volume": "7", "author": "K Walter", "year": "2008", "unstructured": "Walter K, Omura N, Hong SM, Griffith M, Goggins M (2008) Pancreatic cancer associated fibroblasts display normal allelotypes. Cancer Biol Ther 7:882\u2013888", "journal-title": "Cancer Biol Ther"}, {"key": "1139_CR39", "doi-asserted-by": "crossref", "first-page": "29", "DOI": "10.1158/0008-5472.CAN-05-2508", "volume": "66", "author": "H Fiegl", "year": "2006", "unstructured": "Fiegl H, Millinger S, Goebel G, Muller-Holzner E, Marth C, Laird PW, Widschwendter M (2006) Breast cancer DNA methylation profiles in cancer cells and tumor stroma: association with HER-2/neu status in primary breast cancer. Cancer Res 66:29\u201333", "journal-title": "Cancer Res"}, {"key": "1139_CR40", "doi-asserted-by": "crossref", "first-page": "899", "DOI": "10.1038/ng1596", "volume": "37", "author": "M Hu", "year": "2005", "unstructured": "Hu M, Yao J, Cai L, Bachman KE, van den Brule F, Velculescu V, Polyak K (2005) Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet 37:899\u2013905", "journal-title": "Nat Genet"}, {"key": "1139_CR41", "doi-asserted-by": "crossref", "first-page": "9900", "DOI": "10.1158/0008-5472.CAN-08-1319", "volume": "68", "author": "L Jiang", "year": "2008", "unstructured": "Jiang L, Gonda TA, Gamble MV, Salas M, Seshan V, Tu S, Twaddell WS, Hegyi P, Lazar G, Steele I, Varro A, Wang TC, Tycko B (2008) Global hypomethylation of genomic DNA in cancer-associated myofibroblasts. Cancer Res 68:9900\u20139908", "journal-title": "Cancer Res"}, {"key": "1139_CR42", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1042/CS20110005", "volume": "121", "author": "R Munker", "year": "2011", "unstructured": "Munker R, Calin GA (2011) MicroRNA profiling in cancer. Clin Sci (Lond) 121:141\u2013158", "journal-title": "Clin Sci (Lond)"}, {"key": "1139_CR43", "doi-asserted-by": "crossref", "first-page": "823", "DOI": "10.1016/S0092-8674(01)00616-X", "volume": "107", "author": "V Ambros", "year": "2001", "unstructured": "Ambros V (2001) MicroRNAs: tiny regulators with great potential. Cell 107:823\u2013826", "journal-title": "Cell"}, {"key": "1139_CR44", "doi-asserted-by": "crossref", "first-page": "281", "DOI": "10.1016/S0092-8674(04)00045-5", "volume": "116", "author": "DP Bartel", "year": "2004", "unstructured": "Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281\u2013297", "journal-title": "Cell"}, {"key": "1139_CR45", "doi-asserted-by": "crossref", "first-page": "17442", "DOI": "10.1074/jbc.M110.107821", "volume": "285", "author": "N Kosaka", "year": "2010", "unstructured": "Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T (2010) Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 285:17442\u201317452", "journal-title": "J Biol Chem"}, {"key": "1139_CR46", "doi-asserted-by": "crossref", "first-page": "447", "DOI": "10.4161/cib.3.5.12339", "volume": "3", "author": "A Zomer", "year": "2010", "unstructured": "Zomer A, Vendrig T, Hopmans ES, van Eijndhoven M, Middeldorp JM, Pegtel DM (2010) Exosomes: Fit to deliver small RNA. Commun Integr Biol 3:447\u2013450", "journal-title": "Commun Integr Biol"}, {"key": "1139_CR47", "doi-asserted-by": "crossref", "first-page": "4387", "DOI": "10.4161/cc.9.21.13674", "volume": "9", "author": "O Aprelikova", "year": "2010", "unstructured": "Aprelikova O, Yu X, Palla J, Wei BR, John S, Yi M, Stephens R, Simpson RM, Risinger JI, Jazaeri A, Niederhuber J (2010) The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts. Cell Cycle 9:4387\u20134398", "journal-title": "Cell Cycle"}, {"key": "1139_CR48", "doi-asserted-by": "crossref", "first-page": "3048", "DOI": "10.1101/gad.1153003", "volume": "17", "author": "G Dobreva", "year": "2003", "unstructured": "Dobreva G, Dambacher J, Grosschedl R (2003) SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression. Genes Dev 17:3048\u20133061", "journal-title": "Genes Dev"}, {"key": "1139_CR49", "doi-asserted-by": "crossref", "first-page": "1032", "DOI": "10.1016/j.cell.2009.03.047", "volume": "137", "author": "S Valastyan", "year": "2009", "unstructured": "Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szasz AM, Wang ZC, Brock JE, Richardson AL, Weinberg RA (2009) A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137:1032\u20131046", "journal-title": "Cell"}, {"key": "1139_CR50", "doi-asserted-by": "crossref", "first-page": "1608", "DOI": "10.1002/eji.200838509", "volume": "39", "author": "R Rouas", "year": "2009", "unstructured": "Rouas R, Fayyad-Kazan H, El Zein N, Lewalle P, Rothe F, Simion A, Akl H, Mourtada M, El Rifai M, Burny A, Romero P, Martiat P, Badran B (2009) Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression. Eur J Immunol 39:1608\u20131618", "journal-title": "Eur J Immunol"}, {"key": "1139_CR51", "doi-asserted-by": "crossref", "first-page": "1107", "DOI": "10.1373/clinchem.2010.144709", "volume": "56", "author": "N Hanoun", "year": "2010", "unstructured": "Hanoun N, Delpu Y, Suriawinata AA, Bournet B, Bureau C, Selves J, Tsongalis GJ, Dufresne M, Buscail L, Cordelier P, Torrisani J (2010) The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis. Clin Chem 56:1107\u20131118", "journal-title": "Clin Chem"}, {"key": "1139_CR52", "doi-asserted-by": "crossref", "first-page": "13556", "DOI": "10.1073/pnas.0803055105", "volume": "105", "author": "A Lujambio", "year": "2008", "unstructured": "Lujambio A, Calin GA, Villanueva A, Ropero S, Sanchez-Cespedes M, Blanco D, Montuenga LM, Rossi S, Nicoloso MS, Faller WJ, Gallagher WM, Eccles SA, Croce CM, Esteller M (2008) A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci USA 105:13556\u201313561", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "1139_CR53", "doi-asserted-by": "crossref", "first-page": "897", "DOI": "10.1002/hep.22160", "volume": "47", "author": "A Budhu", "year": "2008", "unstructured": "Budhu A, Jia HL, Forgues M, Liu CG, Goldstein D, Lam A, Zanetti KA, Ye QH, Qin LX, Croce CM, Tang ZY, Wang XW (2008) Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 47:897\u2013907", "journal-title": "Hepatology"}, {"key": "1139_CR54", "doi-asserted-by": "crossref", "first-page": "2152", "DOI": "10.1101/gad.1820109", "volume": "23", "author": "P Olson", "year": "2009", "unstructured": "Olson P, Lu J, Zhang H, Shai A, Chun MG, Wang Y, Libutti SK, Nakakura EK, Golub TR, Hanahan D (2009) MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer. Genes Dev 23:2152\u20132165", "journal-title": "Genes Dev"}, {"key": "1139_CR55", "doi-asserted-by": "crossref", "first-page": "7244", "DOI": "10.4049/jimmunol.1001573", "volume": "185", "author": "X Liu", "year": "2010", "unstructured": "Liu X, Zhan Z, Xu L, Ma F, Li D, Guo Z, Li N, Cao X (2010) MicroRNA-148/152 impair innate response and antigen presentation of TLR-triggered dendritic cells by targeting CaMKIIalpha. J Immunol 185:7244\u20137251", "journal-title": "J Immunol"}, {"key": "1139_CR56", "doi-asserted-by": "crossref", "first-page": "339", "DOI": "10.1016/S1535-6108(02)00055-7", "volume": "1", "author": "T Lopez", "year": "2002", "unstructured": "Lopez T, Hanahan D (2002) Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis. Cancer Cell 1:339\u2013353", "journal-title": "Cancer Cell"}, {"key": "1139_CR57", "doi-asserted-by": "crossref", "first-page": "493", "DOI": "10.1016/j.molcel.2010.07.023", "volume": "39", "author": "D Iliopoulos", "year": "2010", "unstructured": "Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML, Struhl K (2010) STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell 39:493\u2013506", "journal-title": "Mol Cell"}, {"key": "1139_CR58", "doi-asserted-by": "crossref", "first-page": "12481", "DOI": "10.1073/pnas.0605298103", "volume": "103", "author": "KD Taganov", "year": "2006", "unstructured": "Taganov KD, Boldin MP, Chang KJ, Baltimore D (2006) NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 103:12481\u201312486", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "1139_CR59", "doi-asserted-by": "crossref", "first-page": "4231", "DOI": "10.1038/onc.2011.140", "volume": "30", "author": "M Musumeci", "year": "2011", "unstructured": "Musumeci M, Coppola V, Addario A, Patrizii M, Maugeri-Sacca M, Memeo L, Colarossi C, Francescangeli F, Biffoni M, Collura D, Giacobbe A, D\u2019Urso L, Falchi M, Venneri MA, Muto G, De Maria R, Bonci D (2011) Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer. Oncogene 30:4231\u20134242", "journal-title": "Oncogene"}], "container-title": ["Cancer Immunology, Immunotherapy"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00262-011-1139-7.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s00262-011-1139-7/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00262-011-1139-7", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 24]], "date-time": "2019-05-24T16:33:12Z", "timestamp": 1558715592000}, "score": 22.40512, "issued": {"date-parts": [[2011, 11, 16]]}, "references-count": 59, "journal-issue": {"published-print": {"date-parts": [[2012, 2]]}, "issue": "2"}, "alternative-id": ["1139"], "URL": "http://dx.doi.org/10.1007/s00262-011-1139-7", "relation": {"cites": []}, "ISSN": ["0340-7004", "1432-0851"], "issn-type": [{"value": "0340-7004", "type": "print"}, {"value": "1432-0851", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T04:08:18Z", "timestamp": 1574741298236}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "Suppl 2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal for ImmunoTherapy of Cancer", "J Immunother Cancer"], "published-print": {"date-parts": [[2015]]}, "DOI": "10.1186/2051-1426-3-s2-p447", "type": "journal-article", "created": {"date-parts": [[2015, 11, 5]], "date-time": "2015-11-05T05:01:57Z", "timestamp": 1446699717000}, "page": "P447", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Phase I study of patients with non-muscle invasive bladder cancer (NMIBC) treated with vesigenurtacel-L (HS-410) after Bacillus Calmette-Gu\u00e9rin (BCG)"], "prefix": "10.1186", "volume": "3", "author": [{"given": "Gary", "family": "Steinberg", "sequence": "first", "affiliation": []}, {"given": "Neal", "family": "Shore", "sequence": "additional", "affiliation": []}, {"given": "Lawrence", "family": "Karsh", "sequence": "additional", "affiliation": []}, {"given": "James", "family": "Bailen", "sequence": "additional", "affiliation": []}, {"given": "Michael", "family": "Woods", "sequence": "additional", "affiliation": []}, {"given": "Taylor", "family": "Schreiber", "sequence": "additional", "affiliation": []}, {"given": "Melissa", "family": "Price", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Journal for ImmunoTherapy of Cancer"], "language": "en", "deposited": {"date-parts": [[2016, 5, 16]], "date-time": "2016-05-16T17:24:05Z", "timestamp": 1463419445000}, "score": 22.325628, "issued": {"date-parts": [[2015]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2015]]}, "issue": "Suppl 2"}, "alternative-id": ["2051-1426-3-S2-P447"], "URL": "http://dx.doi.org/10.1186/2051-1426-3-s2-p447", "ISSN": ["2051-1426"], "issn-type": [{"value": "2051-1426", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T02:28:36Z", "timestamp": 1574216916383}, "reference-count": 36, "publisher": "Wiley", "issue": "3", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 16071, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer"], "published-print": {"date-parts": [[1971, 9]]}, "DOI": "10.1002/1097-0142(197109)28:3<647::aid-cncr2820280317>3.0.co;2-2", "type": "journal-article", "created": {"date-parts": [[2006, 6, 29]], "date-time": "2006-06-29T03:29:48Z", "timestamp": 1151551788000}, "page": "647-654", "source": "Crossref", "is-referenced-by-count": 17, "title": ["L2C guinea pig leukemia: Immunoprotection and immunotherapy"], "prefix": "10.1002", "volume": "28", "author": [{"given": "Leonard", "family": "Ellman", "sequence": "first", "affiliation": []}, {"given": "Ira", "family": "Green", "sequence": "additional", "affiliation": []}], "member": "311", "reference": [{"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB1", "author": "Alexander", "volume": "10", "first-page": "23", "year": "1968", "journal-title": "Progr. Exp. Tumor Res."}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB2", "author": "Bach", "volume": "166", "first-page": "1520", "year": "1969", "journal-title": "Science", "DOI": "10.1126/science.166.3912.1520", "doi-asserted-by": "crossref"}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB3", "author": "Churchill", "volume": "42", "first-page": "13", "year": "1968", "journal-title": "J. Nat. Cancer Inst."}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB4", "author": "Congdon", "volume": "30", "first-page": "337", "year": "1954", "journal-title": "Amer. J. Path."}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB5", "author": "Ellman", "volume": "66", "first-page": "322", "year": "1970", "journal-title": "Proc. U.S. Nat. Acad. Sci.", "DOI": "10.1073/pnas.66.2.322", "doi-asserted-by": "crossref"}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB6", "author": "Ellman", "volume": "1", "first-page": "445", "year": "1970", "journal-title": "Cell. Immunol.", "DOI": "10.1016/0008-8749(70)90020-1", "doi-asserted-by": "crossref"}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB7", "author": "Ellman", "year": "1970", "unstructured": "and : Demonstration of a tumor specific transplantation antigen in syngeneic L2C guinea pig leukemia (abstr.). Thirteenth Annual Meeting, Amer. Soc. of Hemat. 1970."}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB8", "author": "Fass", "volume": "282", "first-page": "776", "year": "1970", "journal-title": "New Eng. J. Med.", "DOI": "10.1056/NEJM197004022821404", "doi-asserted-by": "crossref"}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB9", "author": "Fridman", "volume": "224", "first-page": "277", "year": "1969", "journal-title": "Nature", "DOI": "10.1038/224277a0", "doi-asserted-by": "crossref"}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB10", "author": "Green", "volume": "125", "first-page": "511", "year": "1967", "journal-title": "J. Exp. Med.", "DOI": "10.1084/jem.125.3.511", "doi-asserted-by": "crossref"}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB11", "author": "Gross", "volume": "43", "first-page": "193", "year": "1970", "journal-title": "Acta Hemat.", "DOI": "10.1159/000208730", "doi-asserted-by": "crossref"}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB12", "author": "Gross", "year": "1970", "unstructured": ": Intradermal immunization against leukemia in guinea pigs (abstr). Thirteenth Annual Meeting, Amer. Soc. Hemat., 1970."}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB13", "author": "Hellstrom", "volume": "220", "first-page": "1352", "year": "1968", "journal-title": "Nature", "DOI": "10.1038/2201352a0", "doi-asserted-by": "crossref"}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB14", "author": "Hellstrom", "volume": "12", "first-page": "167", "year": "1969", "journal-title": "Advances Cancer Res.", "DOI": "10.1016/S0065-230X(08)60331-0", "doi-asserted-by": "crossref"}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB15", "author": "Holmes", "volume": "25", "first-page": "373", "year": "1970", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(197002)25:2<373::AID-CNCR2820250215>3.0.CO;2-L", "doi-asserted-by": "crossref"}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB16", "author": "Hughes", "volume": "26", "first-page": "269", "year": "1970", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(197008)26:2<269::AID-CNCR2820260205>3.0.CO;2-X", "doi-asserted-by": "crossref"}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB17", "author": "Ioachim", "year": "1969", "unstructured": "and : Leukemia in guinea pigs. In Proc. Fourth Int. Symp. Comp. Leukemia Res. Cherry Hill, N.J., 1969 (in press).", "volume-title": "Proc. Fourth Int. Symp. Comp. Leukemia Res"}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB18", "author": "Jehn", "volume": "283", "first-page": "329", "year": "1970", "journal-title": "New Eng. J. Med.", "DOI": "10.1056/NEJM197008132830702", "doi-asserted-by": "crossref"}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB19", "author": "Jungeblut", "volume": "51", "first-page": "1153", "year": "1967", "journal-title": "Amer. J. Path."}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB20", "author": "Kanner", "volume": "105", "first-page": "1052", "year": "1970", "journal-title": "J. Immunol."}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB21", "author": "Math\u00e9", "volume": "1", "first-page": "697", "year": "1969", "journal-title": "Lancet", "DOI": "10.1016/S0140-6736(69)92648-8", "doi-asserted-by": "crossref"}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB22", "author": "M\u00f6ller", "volume": "114", "first-page": "415", "year": "1961", "journal-title": "J. Exp. Med.", "DOI": "10.1084/jem.114.4.415", "doi-asserted-by": "crossref"}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB23", "author": "Nadel", "volume": "19", "first-page": "351", "year": "1957", "journal-title": "J. Nat. Cancer Inst.", "DOI": "10.1093/jnci/19.3.351", "doi-asserted-by": "crossref"}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB24", "author": "Nadel", "volume": "38", "first-page": "979", "year": "1967", "journal-title": "J. Nat. Cancer Inst"}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB25", "author": "Oettgen", "volume": "220", "first-page": "295", "year": "1968", "journal-title": "Nature", "DOI": "10.1038/220295a0", "doi-asserted-by": "crossref"}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB26", "author": "Old", "volume": "21", "first-page": "1281", "year": "1961", "journal-title": "Cancer Res."}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB27", "author": "Old", "volume": "15", "first-page": "167", "year": "1964", "journal-title": "Ann. Rev. Med.", "DOI": "10.1146/annurev.me.15.020164.001123", "doi-asserted-by": "crossref"}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB28", "author": "Opler", "volume": "38", "first-page": "797", "year": "1967", "journal-title": "J. Nat. Cancer Inst."}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB29", "author": "Rapp", "volume": "41", "first-page": "1", "year": "1968", "journal-title": "J. Nat. Cancer Inst."}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB30", "author": "Sarma", "year": "1969", "unstructured": "et al.: L2C/N-B guinea pig leukemia: failure to demonstrate a transmissible leukemogenic virus. In Proc. Fourth Int. Symp. Comp. Leukemia Res. Cherry Hill, N.J., 1969 (in press).", "volume-title": "Proc. Fourth Int. Symp. Comp. Leukemia Res"}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB31", "author": "Skurkovich", "volume": "223", "first-page": "509", "year": "1969", "journal-title": "Nature", "DOI": "10.1038/223509a0", "doi-asserted-by": "crossref"}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB32", "author": "Skurkovich", "volume": "33", "first-page": "186", "year": "1969", "journal-title": "Blood"}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB33", "author": "Smith", "volume": "278", "first-page": "1207", "year": "1968", "journal-title": "New Eng. J. Med.", "DOI": "10.1056/NEJM196805302782206", "doi-asserted-by": "crossref"}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB34", "author": "Weiss", "volume": "190", "first-page": "889", "year": "1961", "journal-title": "Nature", "DOI": "10.1038/190889a0", "doi-asserted-by": "crossref"}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB35", "author": "Weiss", "volume": "124", "first-page": "1039", "year": "1966", "journal-title": "J. Exp. Med.", "DOI": "10.1084/jem.124.6.1039", "doi-asserted-by": "crossref"}, {"key": "10.1002/1097-0142(197109)28:3<647::AID-CNCR2820280317>3.0.CO;2-2-BIB36", "author": "Wepsic", "volume": "45", "first-page": "99", "year": "1970", "journal-title": "J. Nat. Cancer Inst."}], "container-title": ["Cancer"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197109)28:3%3C647::AID-CNCR2820280317%3E3.0.CO;2-2", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197109)28:3%3C647::AID-CNCR2820280317%3E3.0.CO;2-2", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 1, 11]], "date-time": "2019-01-11T03:37:36Z", "timestamp": 1547177856000}, "score": 22.221157, "issued": {"date-parts": [[1971, 9]]}, "references-count": 36, "journal-issue": {"published-print": {"date-parts": [[1971, 9]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1002/1097-0142(197109)28:3<647::aid-cncr2820280317>3.0.co;2-2", "relation": {"cites": []}, "ISSN": ["0008-543X", "1097-0142"], "issn-type": [{"value": "0008-543X", "type": "print"}, {"value": "1097-0142", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T01:24:06Z", "timestamp": 1574558646139}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "S3", "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["j. immunotherapy cancer"], "published-print": {"date-parts": [[2014, 12]]}, "DOI": "10.1186/2051-1426-2-s3-p255", "type": "journal-article", "created": {"date-parts": [[2014, 11, 6]], "date-time": "2014-11-06T14:13:27Z", "timestamp": 1415283207000}, "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Immune-cancer interactions in tumors and tumor-draining lymph nodes: Novel prognostic indicators for breast cancer"], "prefix": "10.1186", "volume": "2", "author": [{"given": "James", "family": "Mansfield", "sequence": "first", "affiliation": []}, {"given": "Peter", "family": "Lee", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2014, 11, 6]]}, "container-title": ["Journal for ImmunoTherapy of Cancer"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1186/2051-1426-2-S3-P255.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 1, 22]], "date-time": "2019-01-22T07:11:39Z", "timestamp": 1548141099000}, "score": 21.917202, "issued": {"date-parts": [[2014, 11, 6]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2014, 12]]}, "issue": "S3"}, "alternative-id": ["706"], "URL": "http://dx.doi.org/10.1186/2051-1426-2-s3-p255", "ISSN": ["2051-1426"], "issn-type": [{"value": "2051-1426", "type": "electronic"}], "assertion": [{"value": "6 November 2014", "order": 1, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}], "article-number": "P255"}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T10:16:14Z", "timestamp": 1575108974738}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "11", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2003, 11, 1]], "date-time": "2003-11-01T00:00:00Z", "timestamp": 1067644800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Immunology, Immunotherapy"], "published-print": {"date-parts": [[2003, 11, 1]]}, "DOI": "10.1007/s00262-003-0426-3", "type": "journal-article", "created": {"date-parts": [[2003, 11, 24]], "date-time": "2003-11-24T19:32:01Z", "timestamp": 1069702321000}, "page": "680-685", "source": "Crossref", "is-referenced-by-count": 19, "title": ["On combining antineoplastic drugs with tumor vaccines"], "prefix": "10.1007", "volume": "52", "author": [{"given": "Alicia", "family": "Terando", "sequence": "first", "affiliation": []}, {"given": "James J.", "family": "Mul\ufffd", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Cancer Immunology, Immunotherapy"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00262-003-0426-3.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s00262-003-0426-3/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00262-003-0426-3", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 24]], "date-time": "2019-05-24T16:19:23Z", "timestamp": 1558714763000}, "score": 21.831085, "issued": {"date-parts": [[2003, 11, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2003, 11, 1]]}, "issue": "11"}, "alternative-id": ["2P9FNCUG6GGBJ35X"], "URL": "http://dx.doi.org/10.1007/s00262-003-0426-3", "ISSN": ["0340-7004", "1432-0851"], "issn-type": [{"value": "0340-7004", "type": "print"}, {"value": "1432-0851", "type": "electronic"}], "subject": ["Immunology", "Immunology and Allergy", "Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T19:35:36Z", "timestamp": 1575228936335}, "reference-count": 0, "publisher": "Oxford University Press", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2013, 5]]}, "abstract": "<p>Chapter 8b discusses the considerable controversy as to the optimal management of localized, muscle invasive bladder cancer. Surgical removal of the bladder is considered the \u2018gold standard\u2019 in many countries but there is no randomized trial to underpin this statement, and many patients are unfit for surgery. Reported 5-year survival rates with radiotherapy are remarkably similar to surgical series. Thus even if surgery is genuinely better than radiotherapy for patients fit for both approaches, there are many patients for whom radical surgery is simply not suitable and hence bladder-preserving techniques are appropriate.</p>", "DOI": "10.1093/med/9780199696567.003.0010", "type": "book", "created": {"date-parts": [[2013, 5, 30]], "date-time": "2013-05-30T09:54:09Z", "timestamp": 1369907649000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Bladder cancer"], "prefix": "10.1093", "author": [{"given": "Nicholas", "family": "James", "sequence": "first", "affiliation": []}, {"given": "Elizabeth", "family": "Southgate", "sequence": "additional", "affiliation": []}, {"given": "Anjali", "family": "Zarkar", "sequence": "additional", "affiliation": []}], "member": "286", "container-title": ["Oxford Medicine Online"], "original-title": ["Bladder cancer"], "deposited": {"date-parts": [[2019, 6, 28]], "date-time": "2019-06-28T09:28:00Z", "timestamp": 1561714080000}, "score": 21.584455, "issued": {"date-parts": [[2013, 5]]}, "references-count": 0, "URL": "http://dx.doi.org/10.1093/med/9780199696567.003.0010"}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T22:04:34Z", "timestamp": 1574719474181}, "reference-count": 0, "publisher": "Portland Press Ltd.", "issue": "2", "content-domain": {"domain": ["portlandpress.com"], "crossmark-restriction": true}, "published-print": {"date-parts": [[1997, 5, 1]]}, "DOI": "10.1042/bst025363s", "type": "journal-article", "created": {"date-parts": [[2015, 8, 11]], "date-time": "2015-08-11T13:52:14Z", "timestamp": 1439301134000}, "page": "363S-363S", "update-policy": "http://dx.doi.org/10.1042/crossmark_policy", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Are \u03b3\u03b4 T lymphocytes involved in intravesical bacillus Calmette-Guerin immunotherapy of bladder cancer?"], "prefix": "10.1042", "volume": "25", "author": [{"given": "ANTON B.", "family": "ALEXANDROFF", "sequence": "first", "affiliation": [{"name": "Dept Surgery, Edinburgh University Medical School, Teviot Place, EH8 9AG, UK"}]}, {"given": "JAMES", "family": "BLACK", "sequence": "additional", "affiliation": [{"name": "Dept Surgery, Edinburgh University Medical School, Teviot Place, EH8 9AG, UK"}]}, {"given": "PRESAD", "family": "BOLLINA", "sequence": "additional", "affiliation": [{"name": "Dept Surgery, Edinburgh University Medical School, Teviot Place, EH8 9AG, UK"}]}, {"given": "KESAVAN", "family": "ESUVARANATHAN", "sequence": "additional", "affiliation": [{"name": "Dept Surgery, Singapore National University, Singapore"}]}, {"given": "KEITH", "family": "JAMES", "sequence": "additional", "affiliation": [{"name": "Dept Surgery, Edinburgh University Medical School, Teviot Place, EH8 9AG, UK"}]}], "member": "288", "container-title": ["Biochemical Society Transactions"], "language": "en", "link": [{"URL": "http://portlandpress.com/biochemsoctrans/article-pdf/25/2/363S/539335/bst025363s.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "http://portlandpress.com/biochemsoctrans/article-pdf/25/2/363S/539335/bst025363s.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 25]], "date-time": "2019-10-25T05:09:46Z", "timestamp": 1571980186000}, "score": 21.583952, "issued": {"date-parts": [[1997, 5, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1997, 5, 1]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.1042/bst025363s", "ISSN": ["0300-5127", "1470-8752"], "issn-type": [{"value": "0300-5127", "type": "print"}, {"value": "1470-8752", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T02:22:28Z", "timestamp": 1574216548456}, "reference-count": 8, "publisher": "Wiley", "issue": "3", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 21672, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer"], "published-print": {"date-parts": [[1956, 5]]}, "DOI": "10.1002/1097-0142(195605/06)9:3<622::aid-cncr2820090329>3.0.co;2-z", "type": "journal-article", "created": {"date-parts": [[2006, 6, 26]], "date-time": "2006-06-26T16:16:44Z", "timestamp": 1151338604000}, "page": "622-625", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Hormonal influences on the experimental production of bladder tumors in dogs"], "prefix": "10.1002", "volume": "9", "author": [{"given": "Victor F.", "family": "Marshall", "sequence": "first", "affiliation": []}, {"given": "James L.", "family": "Green", "sequence": "additional", "affiliation": []}, {"given": "John J.", "family": "Harris", "sequence": "additional", "affiliation": []}], "member": "311", "reference": [{"key": "10.1002/1097-0142(195605/06)9:3<622::AID-CNCR2820090329>3.0.CO;2-Z-BIB1", "author": "Allison", "volume": "54", "first-page": "593", "year": "1954", "journal-title": "J. Nutrition", "DOI": "10.1093/jn/54.4.593", "doi-asserted-by": "crossref"}, {"key": "10.1002/1097-0142(195605/06)9:3<622::AID-CNCR2820090329>3.0.CO;2-Z-BIB2", "author": "Bonser", "volume": "6", "first-page": "412", "year": "1952", "journal-title": "Brit. J. Cancer", "DOI": "10.1038/bjc.1952.47", "doi-asserted-by": "crossref"}, {"key": "10.1002/1097-0142(195605/06)9:3<622::AID-CNCR2820090329>3.0.CO;2-Z-BIB3", "author": "Gehrmann", "volume": "107", "first-page": "1436", "year": "1936", "journal-title": "J. A. M. A.", "DOI": "10.1001/jama.1936.02770440012003", "doi-asserted-by": "crossref"}, {"key": "10.1002/1097-0142(195605/06)9:3<622::AID-CNCR2820090329>3.0.CO;2-Z-BIB4", "author": "Hueper", "volume": "20", "first-page": "46", "year": "1938", "journal-title": "J. Indust. Hyg. & Toxicol."}, {"key": "10.1002/1097-0142(195605/06)9:3<622::AID-CNCR2820090329>3.0.CO;2-Z-BIB5", "author": "Huggins", "volume": "1", "first-page": "293", "year": "1941", "journal-title": "Cancer Research"}, {"key": "10.1002/1097-0142(195605/06)9:3<622::AID-CNCR2820090329>3.0.CO;2-Z-BIB6", "author": "Leathem", "volume": "2", "first-page": "30", "year": "1955", "journal-title": "Proc. Am. A. Cancer Research"}, {"key": "10.1002/1097-0142(195605/06)9:3<622::AID-CNCR2820090329>3.0.CO;2-Z-BIB7", "author": "McDonald", "volume": "71", "first-page": "560", "year": "1954", "journal-title": "J. Urol.", "DOI": "10.1016/S0022-5347(17)67826-1", "doi-asserted-by": "crossref"}, {"key": "10.1002/1097-0142(195605/06)9:3<622::AID-CNCR2820090329>3.0.CO;2-Z-BIB8", "author": "Papanicolaou", "volume": "67", "first-page": "247", "year": "1948", "journal-title": "Proc. Soc. Exper. Biol. & Med.", "DOI": "10.3181/00379727-67-16267", "doi-asserted-by": "crossref"}], "container-title": ["Cancer"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(195605%2F06)9:3%3C622::AID-CNCR2820090329%3E3.0.CO;2-Z", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(195605/06)9:3%3C622::AID-CNCR2820090329%3E3.0.CO;2-Z", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 19]], "date-time": "2019-04-19T15:56:30Z", "timestamp": 1555689390000}, "score": 21.326988, "issued": {"date-parts": [[1956, 5]]}, "references-count": 8, "journal-issue": {"published-print": {"date-parts": [[1956, 5]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1002/1097-0142(195605/06)9:3<622::aid-cncr2820090329>3.0.co;2-z", "relation": {"cites": []}, "ISSN": ["0008-543X", "1097-0142"], "issn-type": [{"value": "0008-543X", "type": "print"}, {"value": "1097-0142", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T05:07:40Z", "timestamp": 1574485660357}, "reference-count": 30, "publisher": "Future Medicine Ltd", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Immunotherapy"], "published-print": {"date-parts": [[2011, 1]]}, "DOI": "10.2217/imt.10.77", "type": "journal-article", "created": {"date-parts": [[2010, 12, 21]], "date-time": "2010-12-21T17:04:00Z", "timestamp": 1292951040000}, "page": "27-31", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Therapeutic cancer vaccine fulfills the promise of immunotherapy in prostate cancer"], "prefix": "10.2217", "volume": "3", "author": [{"given": "Ravi A", "family": "Madan", "sequence": "first", "affiliation": []}, {"given": "James L", "family": "Gulley", "sequence": "additional", "affiliation": []}], "member": "1057", "reference": [{"key": "ref-1", "DOI": "10.1111/j.1464-410X.2005.05798.x", "doi-asserted-by": "publisher"}, {"key": "ref-2", "DOI": "10.1056/NEJMoa040720", "doi-asserted-by": "publisher"}, {"key": "ref-3", "DOI": "10.1056/NEJMoa041318", "doi-asserted-by": "publisher"}, {"key": "ref-4", "author": "Moore", "volume": "12", "first-page": "689", "year": "1994", "journal-title": "J. Clin. Oncol.", "DOI": "10.1200/JCO.1994.12.4.689", "doi-asserted-by": "crossref"}, {"key": "ref-6", "author": "Oesterling", "volume": "145", "first-page": "907", "year": "1991", "journal-title": "J. Urol.", "DOI": "10.1016/S0022-5347(17)38491-4", "doi-asserted-by": "crossref"}, {"key": "ref-7", "DOI": "10.1586/14760584.5.2.199", "doi-asserted-by": "publisher"}, {"key": "ref-8", "DOI": "10.1677/erc.1.00950", "doi-asserted-by": "publisher"}, {"key": "ref-9", "author": "Vihko", "volume": "236", "first-page": "275", "year": "1988", "journal-title": "FEBS Lett.", "DOI": "10.1016/0014-5793(88)80037-1", "doi-asserted-by": "crossref"}, {"key": "ref-10", "author": "Rini", "volume": "4", "first-page": "76", "year": "2002", "journal-title": "Curr. Opin. Mol. Ther."}, {"key": "ref-11", "DOI": "10.1345/aph.1K429", "doi-asserted-by": "publisher"}, {"key": "ref-12", "author": "Burch", "volume": "6", "first-page": "2175", "year": "2000", "journal-title": "Clin. Cancer Res."}, {"key": "ref-13", "author": "Small", "volume": "18", "first-page": "3894", "year": "2000", "journal-title": "J. Clin. Oncol.", "DOI": "10.1200/JCO.2000.18.23.3894", "doi-asserted-by": "crossref"}, {"key": "ref-14", "DOI": "10.1200/JCO.2005.04.5252", "doi-asserted-by": "publisher"}, {"key": "ref-15", "DOI": "10.1002/cncr.24429", "doi-asserted-by": "publisher"}, {"key": "ref-16", "author": "Madan", "volume": "23", "first-page": "4720", "year": "2005", "journal-title": "J. Clin. Oncol.", "DOI": "10.1200/jco.2005.23.16_suppl.4720", "doi-asserted-by": "crossref"}, {"key": "ref-17", "DOI": "10.1056/NEJMoa1001294", "doi-asserted-by": "publisher"}, {"key": "ref-18", "DOI": "10.1007/s00262-009-0782-8", "doi-asserted-by": "publisher"}, {"key": "ref-20", "author": "Kelly", "volume": "28", "first-page": "LBA4511", "year": "2010", "journal-title": "J. Clin. Oncol.", "DOI": "10.1200/jco.2010.28.18_suppl.lba4511", "doi-asserted-by": "crossref"}, {"key": "ref-21", "DOI": "10.1200/JCO.2009.25.0597", "doi-asserted-by": "publisher"}, {"key": "ref-22", "DOI": "10.1056/NEJMoa1003466", "doi-asserted-by": "publisher"}, {"key": "ref-23", "author": "Yang", "volume": "175", "first-page": "3715", "year": "2005", "journal-title": "J. Immunol.", "DOI": "10.4049/jimmunol.175.6.3715", "doi-asserted-by": "crossref"}, {"key": "ref-24", "DOI": "10.1073/pnas.251140998", "doi-asserted-by": "publisher"}, {"key": "ref-25", "author": "Aragon-Ching", "volume": "12", "first-page": "4957", "year": "2007", "journal-title": "Front. Biosci.", "DOI": "10.2741/2441", "doi-asserted-by": "crossref"}, {"key": "ref-26", "author": "Drake", "volume": "7", "first-page": "239", "year": "2005", "journal-title": "Cancer Cell", "DOI": "10.1016/j.ccr.2005.01.027", "doi-asserted-by": "crossref"}, {"key": "ref-27", "author": "Chan", "volume": "49", "first-page": "181", "year": "2000", "journal-title": "Cancer Immunol. Immunother.", "DOI": "10.1007/s002620000122", "doi-asserted-by": "crossref"}, {"key": "ref-28", "DOI": "10.1158/1078-0432.CCR-07-4025", "doi-asserted-by": "publisher"}, {"key": "ref-29", "author": "Quarmby", "volume": "20", "first-page": "3375", "year": "2000", "journal-title": "Anticancer Res."}, {"key": "ref-30", "DOI": "10.2174/1381612023394089", "doi-asserted-by": "publisher"}, {"key": "ref-31", "DOI": "10.4049/jimmunol.170.12.6338", "doi-asserted-by": "publisher"}, {"key": "ref-33", "DOI": "10.1172/JCI35180", "doi-asserted-by": "publisher"}], "container-title": ["Immunotherapy"], "language": "en", "link": [{"URL": "https://www.futuremedicine.com/doi/pdf/10.2217/imt.10.77", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T09:47:52Z", "timestamp": 1574243272000}, "score": 21.211037, "issued": {"date-parts": [[2011, 1]]}, "references-count": 30, "journal-issue": {"published-print": {"date-parts": [[2011, 1]]}, "issue": "1"}, "alternative-id": ["10.2217/imt.10.77"], "URL": "http://dx.doi.org/10.2217/imt.10.77", "relation": {"cites": []}, "ISSN": ["1750-743X", "1750-7448"], "issn-type": [{"value": "1750-743X", "type": "print"}, {"value": "1750-7448", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T01:34:40Z", "timestamp": 1574818480080}, "reference-count": 38, "publisher": "Future Medicine Ltd", "issue": "9", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Immunotherapy"], "published-print": {"date-parts": [[2017, 8]]}, "DOI": "10.2217/imt-2017-0059", "type": "journal-article", "created": {"date-parts": [[2017, 8, 3]], "date-time": "2017-08-03T14:31:15Z", "timestamp": 1501770675000}, "page": "695-699", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Convergence of immunotherapy, radiotherapy and prostate cancer: challenges and opportunities"], "prefix": "10.2217", "volume": "9", "author": [{"given": "Michael", "family": "Green", "sequence": "first", "affiliation": [{"name": "Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA"}]}, {"given": "Felix Y", "family": "Feng", "sequence": "additional", "affiliation": [{"name": "Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA"}]}, {"given": "Rohit", "family": "Mehra", "sequence": "additional", "affiliation": [{"name": "Department of Pathology, University of Michigan, Ann Arbor, MI, USA"}]}, {"given": "Daniel E", "family": "Spratt", "sequence": "additional", "affiliation": [{"name": "Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA"}]}], "member": "1057", "reference": [{"key": "B1", "DOI": "10.3322/caac.21332", "doi-asserted-by": "publisher"}, {"key": "B2", "DOI": "10.1056/NEJMoa1001294", "doi-asserted-by": "publisher"}, {"key": "B3", "DOI": "10.1200/JCO.2014.59.4358", "doi-asserted-by": "publisher"}, {"key": "B4", "DOI": "10.1038/bjc.2015.124", "doi-asserted-by": "publisher"}, {"key": "B5", "DOI": "10.1126/scitranslmed.aad7118", "doi-asserted-by": "publisher"}, {"key": "B6", "DOI": "10.1200/JCO.2016.69.1584", "doi-asserted-by": "publisher"}, {"key": "B7", "DOI": "10.1053/j.seminoncol.2015.02.004", "doi-asserted-by": "publisher"}, {"key": "B8", "DOI": "10.18632/oncotarget.10547", "doi-asserted-by": "publisher"}, {"key": "B9", "DOI": "10.1038/nature12477", "doi-asserted-by": "publisher"}, {"key": "B10", "DOI": "10.3390/cancers4010193", "doi-asserted-by": "publisher"}, {"key": "B11", "DOI": "10.1038/ni1102-991", "doi-asserted-by": "publisher"}, {"key": "B12", "DOI": "10.1002/ijc.29538", "doi-asserted-by": "publisher"}, {"key": "B13", "DOI": "10.1002/ijc.2910600209", "doi-asserted-by": "publisher"}, {"key": "B14", "DOI": "10.1158/1078-0432.CCR-13-3271", "doi-asserted-by": "publisher"}, {"key": "B15", "DOI": "10.1002/pros.21020", "doi-asserted-by": "publisher"}, {"key": "B16", "DOI": "10.1038/nature21676", "doi-asserted-by": "publisher"}, {"key": "B17", "DOI": "10.1038/nm.4308", "doi-asserted-by": "publisher"}, {"key": "B18", "year": "2012", "volume-title": "Devita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology Review"}, {"key": "B19", "DOI": "10.1038/nm1622", "doi-asserted-by": "publisher"}, {"key": "B20", "DOI": "10.1016/j.immuni.2014.10.019", "doi-asserted-by": "publisher"}, {"key": "B21", "DOI": "10.1038/nature14292", "doi-asserted-by": "publisher"}, {"key": "B22", "DOI": "10.1001/jamaoncol.2015.2756", "doi-asserted-by": "publisher"}, {"key": "B23", "DOI": "10.1056/NEJMoa1112824", "doi-asserted-by": "publisher"}, {"key": "B24", "DOI": "10.1016/S1470-2045(14)70189-5", "doi-asserted-by": "publisher"}, {"issue": "15", "key": "B25", "first-page": "5138", "volume": "27", "author": "Slovin SF", "year": "2009", "journal-title": "J. Clin. Oncol."}, {"key": "B26", "DOI": "10.1016/j.ijrobp.2010.11.054", "doi-asserted-by": "publisher"}, {"key": "B27", "DOI": "10.1038/onc.2015.5", "doi-asserted-by": "publisher"}, {"key": "B28", "DOI": "10.1016/j.ijrobp.2012.05.023", "doi-asserted-by": "publisher"}, {"key": "B29", "DOI": "10.1158/2159-8290.CD-13-0172", "doi-asserted-by": "publisher"}, {"key": "B30", "DOI": "10.1172/JCI64096", "doi-asserted-by": "publisher"}, {"key": "B31", "DOI": "10.1186/1741-7015-9-51", "doi-asserted-by": "publisher"}, {"key": "B32", "DOI": "10.1016/S0264-410X(99)00513-7", "doi-asserted-by": "publisher"}, {"key": "B33", "DOI": "10.1073/pnas.1402468111", "doi-asserted-by": "publisher"}, {"issue": "9", "key": "B34", "first-page": "1002", "volume": "70", "author": "Arredouani MS", "year": "2010", "journal-title": "Prostate"}, {"key": "B35", "DOI": "10.4049/jimmunol.173.10.6098", "doi-asserted-by": "publisher"}, {"key": "B36", "DOI": "10.1073/pnas.251140998", "doi-asserted-by": "publisher"}, {"key": "B37", "DOI": "10.1016/j.juro.2010.02.1055", "doi-asserted-by": "publisher"}, {"key": "B38", "DOI": "10.1016/j.ijrobp.2016.06.025", "doi-asserted-by": "publisher"}], "container-title": ["Immunotherapy"], "language": "en", "link": [{"URL": "https://www.futuremedicine.com/doi/pdf/10.2217/imt-2017-0059", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T09:56:09Z", "timestamp": 1574243769000}, "score": 21.03777, "issued": {"date-parts": [[2017, 8]]}, "references-count": 38, "journal-issue": {"published-print": {"date-parts": [[2017, 8]]}, "issue": "9"}, "alternative-id": ["10.2217/imt-2017-0059"], "URL": "http://dx.doi.org/10.2217/imt-2017-0059", "relation": {"cites": []}, "ISSN": ["1750-743X", "1750-7448"], "issn-type": [{"value": "1750-743X", "type": "print"}, {"value": "1750-7448", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 29]], "date-time": "2019-11-29T18:27:23Z", "timestamp": 1575052043880}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "3", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1996, 12, 10]], "date-time": "1996-12-10T00:00:00Z", "timestamp": 850176000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Immunology, Immunotherapy"], "published-print": {"date-parts": [[1996, 12, 10]]}, "DOI": "10.1007/s002620050313", "type": "journal-article", "created": {"date-parts": [[2002, 8, 25]], "date-time": "2002-08-25T08:03:26Z", "timestamp": 1030262606000}, "page": "127-134", "source": "Crossref", "is-referenced-by-count": 41, "title": ["Carcinoembryonic antigen as a target for cancer vaccines"], "prefix": "10.1007", "volume": "43", "author": [{"given": "James W.", "family": "Hodge", "sequence": "first", "affiliation": []}, {"given": "J.", "family": "Schlom", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Cancer Immunology, Immunotherapy"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s002620050313.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s002620050313/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s002620050313", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 24]], "date-time": "2019-05-24T16:33:32Z", "timestamp": 1558715612000}, "score": 20.975363, "issued": {"date-parts": [[1996, 12, 10]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1996, 12, 10]]}, "issue": "3"}, "alternative-id": ["VCWLUB7UJV49N61W"], "URL": "http://dx.doi.org/10.1007/s002620050313", "ISSN": ["0340-7004", "1432-0851"], "issn-type": [{"value": "0340-7004", "type": "print"}, {"value": "1432-0851", "type": "electronic"}], "subject": ["Immunology", "Immunology and Allergy", "Cancer Research", "Oncology"]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}